Price Chart
Key Statistics
Previous Close
$31.45Day Range
52-Week Range
Avg Volume
20.1KDividend Yield
1.27%Expense Ratio
0.59%AUM
$59.2MShares Outstanding
1.3METF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 42.78% |
| China | 18.98% |
| Denmark | 18.67% |
| Japan | 5.48% |
| South Korea | 4.46% |
| United Kingdom | 3.22% |
| Switzerland | 3.12% |
| Hong Kong | 2.55% |
| Other | 0.75% |
Fund Information
- Issuer
- Roundhill Investments
- Category
- Healthcare
- Types
- Pharma
- Inception Date
- May 21, 2024
- Exchange
- NASDAQ
- Description
- Roundhill believes that weight loss drugs, including GLP-1 agonists, represent one of the most revolutionary advancements in the global pharmaceuticals industry. The Roundhill GLP-1 & Weight Loss ETF (“OZEM”) is the world’s first GLP-1 ETF. OZEM is an actively-managed ETF.
Similar ETFs
The Roundhill Investments - GLP-1 & Weight Loss ETF (OZEM) is an exchange-traded fund issued by Roundhill Investments that launched on May 21, 2024. It currently manages $59.2M in assets under management. The fund charges an expense ratio of 0.59%. The fund holds 29 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 65.3% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | NVO | Novo Nordisk A/S | 12.17% | 163,734 | $7.2M |
| 2 | LLY | Eli Lilly & Co | 12.15% | 6,402 | $7.2M |
| 3 | PFE | Pfizer Inc | 7.50% | 160,549 | $4.4M |
| 4 | 1093.HK | CSPC Pharmaceutical Group Ltd | 6.84% | 3,620,000 | $4.0M |
| 5 | 128940.KS | Hanmi Pharm Co Ltd | 5.01% | 8,245 | $3.0M |
| 6 | VKTX | Viking Therapeutics Inc | 4.93% | 90,906 | $2.9M |
| 7 | KLRA | Kailera Therapeutics Inc | 4.30% | 170,761 | $2.5M |
| 8 | AMGN | Amgen Inc | 4.15% | 6,430 | $2.5M |
| 9 | 4519.T | Chugai Pharmaceutical Co Ltd | 4.13% | 58,700 | $2.4M |
| 10 | 1672.HK | Ascletis Pharma Inc | 4.08% | 1,883,000 | $2.4M |
| 11 | ZEAL.CO | Zealand Pharma A/S | 4.00% | 53,593 | $2.4M |
| 12 | AZN | AstraZeneca PLC | 3.30% | 12,231 | $2.0M |
| 13 | ROP.SW | Roche Holding AG | 3.19% | 4,432 | $1.9M |
| 14 | MBX | MBX Biosciences Inc | 3.16% | 30,701 | $1.9M |
| 15 | 3692.HK | Hansoh Pharmaceutical Group Co Ltd | 2.93% | 408,000 | $1.7M |
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | -0.72% | |
| 1W | -6.69% | |
| 1M | -6.99% | |
| 3M | +1.15% | |
| 6M | -1.85% | |
| YTD | -9.33% | |
| 1Y | +20.72% | |
| 3Y | +22.72% | |
| 5Y | +22.72% |
Moving Averages
$33.19
Below 20-Day MA$32.99
Below 50-Day MA$32.79
Below 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$37.01
Current Price
$31.23
52-Week Low
$25.79
Current Yield
1.27%
Annual Dividend
$0.8729
Frequency
1x/year
Last Ex-Date
Dec 30, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 30, 2025 | $0.4099 | Dec 31, 2025 |
| Dec 30, 2025 | $0.4099 | Dec 31, 2025 |
| Dec 30, 2024 | $0.0531 | Dec 31, 2024 |
Dividend Payments Over Time
Category Comparison
| Metric | OZEM | Healthcare(254 ETFs) | Pharma(29 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.59% | 0.62% | 0.67% |
| AUM | $59.2M | $1.73B | $1.73B |
| Dividend Yield | 1.27% | 3.97% | 1.82% |
| Avg Volume | 20.1K | 364.4K | 353.4K |
| Holdings | 29 | 160 | 38 |
| Performance | |||
| 1-Month Return | -5.75% | -2.86% | -2.61% |
| 6-Month Return | -0.59% | +7.23% | +13.73% |
| YTD Return | -8.85% | +10.59% | +14.41% |
| 1-Year Return | -8.55% | +8.50% | +13.64% |
Compare with Another ETF
Search for an ETF to compare with OZEM:
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.